Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 12, 2026 06:00 ET | Source: PathMaker Neurosystems Inc.

PathMaker Neurosystems Announces Completion of ALS Early-Feasibility Study of the MyoRegulator® Device for Non-Invasive Treatment of ALS

PathMaker Neurosystems Announces Completion of ALS Early Feasibility Study of the MyoRegulator Device for Non-Invasive Treatment of ALS
January 08, 2026 08:00 ET | Source: NeurAxis, Inc.

NeurAxis Achieves Major Milestone with AMA Category I CPT® Code Now in Effect, Establishing a Permanent Reimbursement Pathway

The new CPT code reflects the latest efficacious medical care available to patients, facilitating adoption and utilization.The assignment of a Category I CPT® code demonstrates a strong message to...
January 07, 2026 20:33 ET | Source: Pulsetto

Best Stress Relief Device 2026: Vagus Nerve Stimulator Consumer Search Analysis as Drug-Free Wellness Interest Expands

Best stress relief device consumer search analysis examines Pulsetto vagus nerve stimulator as January 2026 drug-free wellness interest grows.
December 17, 2025 06:00 ET | Source: PathMaker Neurosystems Inc.

PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Use of the MyoRegulator® Neuromodulation Device in ALS For Slowing the Progression of Functional Symptoms

PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Non-Invasive Treatment of ALS Using the MyoRegulator® Neuromodulation Device
December 01, 2025 07:00 ET | Source: NeurAxis, Inc.

NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain

CARMEL, Ind., Dec. 01, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic...
November 18, 2025 10:33 ET | Source: Research and Markets

Cervical Dystonia Research Analysis Report 2025-2035: Market Sees Intense Competition as Ipsen, Merz, and AbbVie Advance Therapies Through Strategic Expansions

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Cervical Dystonia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
November 12, 2025 08:00 ET | Source: NeurAxis, Inc.

NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives

CARMEL, Ind., Nov. 12, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic...
October 22, 2025 06:41 ET | Source: Research and Markets

Spinal Cord Stimulators Market Insights, Competitive Landscape, and Forecast Report 2024-2032: Rising Chronic Pain and Neuropathy Cases, Advancements in Rechargeable Devices, and Regional Growth

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Spinal Cord Stimulators - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ResearchAndMarkets.com's offering. ...
October 01, 2025 07:00 ET | Source: Comphya SA

Comphya Announces First Patient Implanted with CaverSTIM in U.S. Pilot Study at Johns Hopkins University School of Medicine

LAUSANNE, Switzerland, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Comphya SA, a clinical-stage MedTech company pioneering the first implantable neurostimulation therapy for erectile dysfunction (ED)...
September 24, 2025 08:18 ET | Source: Magstim EGI

EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Stimulation

EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Monitoring for Neuroscience Research-New GES 500